Recombinant IL13 (Tralokinumab Biosimilar) antibody
The Mammalian Cells Monoclonal anti-IL13 (Tralokinumab Biosimilar) antibody is suitable to detect IL13 (Tralokinumab Biosimilar) in samples from Human. It has been validated for ELISA.
Catalog No. ABIN7487857
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant IL13 (Tralokinumab Biosimilar) antibody (ABIN7487857)
Target
IL13 (Tralokinumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This IL13 (Tralokinumab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Tralokinumab Biosimilar - Anti-IL13 mAb
-
Characteristics
- Antibody Type: IgG4-lambda
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG4 lambda
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- IL13 (Tralokinumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
CAT-354
Tralokinumab is a human monoclonal antibody which targets the cytokine interleukin 13, and is designed for the treatment of asthma and inflammatory diseases. -
CAS-No
- 1044515-88-9
Target
-
You are here:
